Release
09.06.2017
VALBIOTIS will present the results of its Phase I/II clinical study on the active ingredient of Valedia®, TOTUM-63, during the 77th Scientific Sessions of the American Diabetes Association.
Download
Release
02.06.2017
VALBIOTIS Initial Public Offering records huge success
Download
Release
24.04.2017
Sébastien PELTIER, CEO of VALBIOTIS, presents his vision of diabetes-free world at l’Echappée Volée
Download
Release
12.04.2017
Two partnership agreements to assess the effects of TOTUM-63, the active ingredient Valedia®, on intestinal microbiota
Download
Release
30.03.2017
VALBIOTIS at the 77th scientific sessions of the American Diabetes Association
Download
Release
14.04.2016
Valbiotis at the American Diabetes Congress thanks to its prevention solution
Download
Release
29.01.2016
VALBIOTIS opens a new location in Clermont Ferrand
Download
Release
02.07.2015
VALBIOTIS, winner of I-Lab
Download
Release
22.01.2015
Science at the service of dietary supplements
Download